Pages that link to "Q26865976"
Jump to navigation
Jump to search
The following pages link to Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide (Q26865976):
Displaying 12 items.
- Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus (Q26995493) (← links)
- Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial (Q33466598) (← links)
- Methylglyoxal modulates endothelial nitric oxide synthase-associated functions in EA.hy926 endothelial cells (Q33589250) (← links)
- Atherogenic, fibrotic and glucose utilising actions of glucokinase activators on vascular endothelium and smooth muscle (Q33593675) (← links)
- The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study (Q35038525) (← links)
- The effects of postprandial glucose and insulin levels on postprandial endothelial function in subjects with normal glucose tolerance (Q36316459) (← links)
- Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients (Q36578890) (← links)
- Miglitol improves postprandial endothelial dysfunction in patients with acute coronary syndrome and new-onset postprandial hyperglycemia (Q36952365) (← links)
- Clinical pharmacokinetics and pharmacodynamics of the novel SGLT2 inhibitor ipragliflozin (Q38260349) (← links)
- Pharmacogenomics of glinides. (Q38307994) (← links)
- Comparison of Efficacy and Economic Value of Prandilin 25 and Humalog Mix 25 in Patients with Newly Diagnosed Type 2 Diabetes by a Continuous Glucose Monitoring System (Q91656674) (← links)
- High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus (Q93026142) (← links)